Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Greenwich LifeSciences, Inc. (GLSI) had Weighted-Average Shares Outstanding (Diluted) of 14.62M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-3.95M |
|
-- |
|
-- |
|
$4.02M |
|
$-4.02M |
|
$0.07M |
|
$-3.95M |
|
$-3.95M |
|
$-3.95M |
|
$-3.95M |
|
$-3.95M |
|
$-3.95M |
|
$-4.02M |
|
$-4.02M |
|
14.62M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
14.62M |
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$8.88M |
|
-- |
|
-- |
|
$8.88M |
|
$5.76M |
|
-- |
|
-- |
|
$5.76M |
|
$3.12M |
|
$3.12M |
|
$3.12M |
|
14.68M |
|
| Cash Flow Statement Financials | |
$-6.64M |
|
-- |
|
$9.34M |
|
$6.18M |
|
$8.88M |
|
$2.70M |
|
$3.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-126.68% |
|
-126.68% |
|
-44.49% |
|
-126.68% |
|
$0.21 |
|
$-0.45 |
|
$-0.45 |
|